Peptide Vaccine With Resiquimod as an Immune Modulator for Patients With Resected Melanoma: A Pilot Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Gag 267-274 peptide vaccine; Melanoma vaccine MART-1; Montanide ISA-51; Resiquimod
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics
- 09 Oct 2018 Biomarkers information updated
- 14 Jan 2013 New trial record